Financials
- Market Capitalization 2.29 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
15.16
売上高対価格比率
2.79
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1779 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.73 USD | +2.29% | -5.86% | +10.05% | -11.61% | 2.77 B USD | ||
| 1842 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.13 USD | -9.20% | -19.97% | -69.46% | -69.17% | 2.54 B USD | ||
| 1989 | HCM HUTCHMED (China) Limited - American Depositary Shares | 11.59 USD | +3.02% | +3.67% | +11.55% | -32.81% | 2.02 B USD | ||
| 2057 | ANIP ANI Pharmaceuticals, Inc. - Common Stock | 80.82 USD | +0.34% | -4.00% | -2.63% | -14.59% | 1.84 B USD |